Pharm-Olam releases a corporate overview video

Monday, January 12, 2015

To learn more about the benefits that Pharm-Olam offers click here to view the video.

Pharm-Olam hosts a webinar to explain how political events are affecting clinical trials in Ukraine

Thursday, November 13, 2014

The Ukraine has been a hot topic in the news due to the recent turmoil in the country. Even during these difficult times, drug development and clinical trials continue to be run in the Ukraine, which boasts recruitment figures at least two times higher than those in the United States and Western Europe.

To view a recording of this webinar, click here

Pharm-Olam International Celebrates 20-Year Anniversary

Tuesday, November 04, 2014

HOUSTON, TEXAS - November 4th, 2014.

Pharm-Olam International Ltd., a multi-national, full-service CRO to biopharmaceutical and device industries is proud to celebrate 20 years of successfully helping our sponsors create a healthier world.

Pharm-Olam completes birch and grass pollen allergy studies

Saturday, February 01, 2014

Pharm-Olam was contracted to provide a full-service solution for two Phase II, dose escalation allergy studies that required a total of 500 patients in Europe. With two different allergy indications, Grass Pollen and Birch Pollen, these studies presented some unique challenges.

Pharm-Olam Expands into Israel

Monday, January 13, 2014

In our continued quest to reduce time and effort to bring medicines to market; Pharm-Olam is pleased to announce expansion into Israel. Pharm-Olam continues to look to increase its strategic footprint to offer our clients a greater choice to support their clinical trials. Incorporating Israel into your clinical trials offers you several benefits including:

Pharm-Olam Performs Clinical Trial Services in Kazakhstan, Expands Global Footprint to the Commonwealth of Independent States

Thursday, May 30, 2013

HOUSTON, TX – Pharm-Olam International Ltd. a multi-national, full service provider of outsourced development services to the pharmaceutical and biotech industries, announced its successful expansion of clinical trial services into Kazakhstan.